Biotech Growth Investors & VC Firms
747 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Medicxi
LondonPre-Seed–Late Stage
34 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
S32
Palo AltoSeries A–Late Stage
25 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
26 people
Swanlaab Venture Factory
MadridSeed–Growth$540K – $3.2M
25 people
Ireland Strategic Investment Fund
DublinGrowth–Late Stage
37 people
HealthCap
StockholmSeed–Growth
30 people
Schmidt
SeoulPre-Seed–Growth
FIMI Opportunity Funds
Tel AvivGrowth
2 people
GroveStreet
NewtonSeries A–Late Stage
39 people
NaviMed Capital
RosslynGrowth$5M – $30M
29 people
Safar Partners
CambridgePre-Seed–Late Stage
20 people
PMV
BrusselsPre-Seed–Late Stage
1 person
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
aMoon
Ra'ananaSeed–Late Stage
25 people
McWin Capital Partners
LondonSeries B–Late Stage
31 people
Rho Ventures
New YorkPre-Seed–Late Stage$2M – $15M
10 people
Claret Capital Partners
LondonSeries A–Late Stage
29 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
Movac
AucklandSeed–Late Stage$600K – $3M
26 people
LDC
LondonSeries B–Growth$12.7M – $127M
12 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
16 people
Parkwalk Advisors
LondonSeed–Growth
31 people
Related lists
Growth Investors & VC Firms (4757)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Growth Investors & VC Firms (1213)Enterprise Software Growth Investors & VC Firms (1186)SaaS Growth Investors & VC Firms (1173)Growth Investors & VC Firms in Europe (1149)
Data sourced from public filings and firms' own websites — see our methodology.




































































